| Bioactivity | LRRK2-IN-8 is a LRRK2 inhibitor. LRRK2-IN-8 inhibits LRRK2 (wt) and LRRK2 (G2019) with IC50s lower than 10 nM, and inhibits TYK2 and NUAK1 with IC50s of 10-100 nM[1]. |
| Name | LRRK2-IN-8 |
| CAS | 2770269-44-6 |
| Formula | C16H12F2N6 |
| Molar Mass | 326.30 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jean TASSEL, et al. Kinase modulators and methods of use thereof. Patent. WO2022104206. |
LRRK2-IN-8
CAS: 2770269-44-6 F: C16H12F2N6 W: 326.30
LRRK2-IN-8 is a LRRK2 inhibitor. LRRK2-IN-8 inhibits LRRK2 (wt) and LRRK2 (G2019) with IC50s lower than 10 nM, and inhib
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.